Improving Provider Adherence to the Safe Prescribing of Opioids Standard: An Education and Reminder Intervention by Grewal, Pavan
University of Portland
Pilot Scholars
Nursing Graduate Publications and Presentations School of Nursing
5-2019
Improving Provider Adherence to the Safe
Prescribing of Opioids Standard: An Education and
Reminder Intervention
Pavan Grewal
Follow this and additional works at: https://pilotscholars.up.edu/nrs_gradpubs
Part of the Interprofessional Education Commons, Nursing Commons, and the Substance Abuse
and Addiction Commons
This Doctoral Project is brought to you for free and open access by the School of Nursing at Pilot Scholars. It has been accepted for inclusion in Nursing
Graduate Publications and Presentations by an authorized administrator of Pilot Scholars. For more information, please contact library@up.edu.
Citation: Pilot Scholars Version (Modified MLA Style)
Grewal, Pavan, "Improving Provider Adherence to the Safe Prescribing of Opioids Standard: An Education and Reminder
Intervention" (2019). Nursing Graduate Publications and Presentations. 32.
https://pilotscholars.up.edu/nrs_gradpubs/32
Running head: IMPROVING PROVIDER ADHERENCE 1 
 
 
 
 
 
 
 
 
 
Improving Provider Adherence to the Safe Prescribing of Opioids Standard:  An Education and 
Reminder Intervention 
Pavan Grewal, FNP, MN 
University of Portland Doctor of Nursing Practice Program 
NRS 662: Dr. Anjanette Raber 
    April 15, 2019 
 
 
 
 
 
 
 
 
 
 
 
IMPROVING PROVIDER ADHERENCE  2 
 
 
 The opioid epidemic is a crisis of opioid misuse characterized by higher incidences of 
substance use disorder, overdoses, and deaths in Canada (Belzak & Halverson, 2018).  In Canada 
during 2017, ten people died each day from opioid related incidences such as overdose which is 
greater than deaths from motor vehicle collisions in the previous year (Government of Canada, 
2018; Belzak & Halverson).  British Columbia has one of the highest overdose and mortality 
rates from opioids in Canada (Belzak & Halverson).  In 2017, 12% of Canadian (N = 3, 998) 
overdose deaths were in the Fraser Valley Region that contains about one fourth of British 
Columbia’s population (Fraser Health Authority (FHA), 2018).  The overwhelming number of 
incidences have resulted from both illegal use and over prescribing of opioids.   
 This project was conducted in a clinic in the Fraser Valley Region with primary care 
providers who prescribe opioids.  The Fraser Valley Region has a high rate of people living with 
chronic noncancer pain which is strongly linked to the opioid related incidences in the region 
(FHA, 2018).  The College of Physicians and Surgeons of British Columbia (CPSBC) (2018) 
recently revised their standard for “Safe Prescribing of Opioids and Sedatives” to mitigate the 
contribution of problematic prescriptions, such as over-prescribing of opioids and lack of risk 
assessments by providers.  An important part of the standard states providers must inform 
chronic noncancer pain patients of the risks and benefits of opioids and one way is through 
completing opioid treatment agreements (OTAs).  The OTA serves as an agreement signed by 
patients and providers once the patient is informed of the use and potential harms of the 
prescription by the provider.  
 The primary care clinic for this project serves a large population of patients on long-term 
opioid therapy (LTOT) for chronic noncancer pain.  Prior to this project, the providers 
infrequently completed OTAs with patients decreasing their adherence to the CPSBC standard.  
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The standard specifically holds providers ethically responsible to complete comprehensive 
assessments and documentation when prescribing or refilling LTOT.  The purpose of this project 
was to improve provider adherence to the College of Physicians and Surgeons of British 
Columbia standard through completion of OTAs using a two-part education and clinical 
reminder intervention. 
Background  
Chronic Noncancer Pain 
Chronic noncancer pain includes any condition with pain occurring for three months or 
more not associated with malignant disease (Busse, Craigie, Juurlink et al., 2017).  Chronic 
noncancer pain is a challenging condition to treat as it can interfere with activities of daily living 
and quality of life leading to increased health resource utilization, such as prescription 
medications including opioids (Busse et al., 2017).  Patients with chronic noncancer pain are 
commonly prescribed LTOT and have a higher risk to develop tolerance, dependency, or 
addiction making them vulnerable to opioid related incidences, to the extent of mortality 
(National Institute on Drug Abuse, 2018).  
 In Canada 15% to 19 % of adults have chronic noncancer pain for which many are 
treated with opioids by providers to improve quality of life (Anderson, Zlateva, Khatri et al., 
2015).  However, providers may not adequately address the associated risks of LTOT including 
tolerance, dependency, addiction, abuse, poisoning, overdose, impaired function, accidents, 
injuries, and diversion, all contributing to the opioid epidemic (College of Physicians and 
Surgeons of Alberta, 2017).  Chronic noncancer pain and associated treatment cost more than 
heart disease, cancer, and Human Immunodeficiency Virus combined estimated at greater than 
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$6 billion per year in treatment and another $37 billion related to sick days and job loss 
(Finestone, Juurlink, Power et al., 2016).   
Provider Practice & Opioids 
The opioid epidemic resulted from several factors, one being providers’ prescribing 
practices (Howlett, 2018).  There has been a drastic increase in opioid prescribing with a high 
number of refills taover the past three decades.  Thirty years ago, providers did not regularly 
prescribe opioids for chronic noncancer pain nor understand the harms related to long-term 
prescribing.  In 1996, Canada’s federal government approved prescribing the opioid OxyContin 
to relieve moderate to severe pain for all patients which changed the model for the treatment of 
chronic noncancer pain.  OxyContin was marketed as a drug with lower risk of abuse and 
dependence due to its long-acting and time-release formula compared to shorter acting opioids.  
By the 2000’s, addiction to OxyContin was on the rise and healthcare plans stopped covering the 
opioid.  Providers then began prescribing available shorter acting opioids such as morphine and 
fentanyl to already established LTOT users and new patients suffering with chronic noncancer 
pain.  This resulted in a new class of drug addiction in society due to wider spread use of 
prescription opioids (Howlett).   
Development of the Revised Standard 
Canada has the second highest rate per capita of opioid prescriptions in the world (Belzak 
& Halverson, 2018).  In 2017, 3, 998 people died from opioid related causes (Government of 
Canada, 2018).  British Columbia has the highest rate of deaths related to opioid overdoses at 
37% of the national average equaling 1,482 deaths in 2017 (Government of Canada).  The Fraser 
Valley Region, accounts for 33% of British Columbia’s opioid related deaths, which is one of the 
highest rates in the province (FHA, 2018).  This rate increased by 130% from 2015 to 2017.  
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Additionally, there were 6,630 ambulance attended and over 5,000 Emergency Department visits 
with suspected overdoses in the Fraser Valley Region in 2017 (FHA).  The clinic for this project 
was in the heart of the Fraser Valley Region with primary care providers attending patients 
vulnerable to opioid misuse. 
Primary care providers such as physicians are principal prescribers of opioids for chronic 
noncancer pain and must follow best practice guidelines to reduce patient risks (Khalid et al., 
2015).  In response to the opioid epidemic, Canadian physicians and medical regulators 
recognize the problem and are more involved in initiatives such as developing new guidelines 
(Unger, 2018).  For example, the Canadian opioid practice guideline for chronic noncancer pain 
by the National Pain Centre at McMaster University was recently updated to improve the 
patient’s safety from opioid misuse and combat the epidemic (Anderson et al., 2015).  This new 
2017 guideline is more comprehensive with multiple recommendations for physicians to mitigate 
patient risks from prescription opioids compared to the previous 2010 guideline (McMaster, 
2017).  
  In June 2018, the provincial CPSBC, British Columbia’s physicians’ licensing college, 
followed McMaster University’s lead and revised their previous Safe Prescribing of Drugs with 
Potential for Misuse/Diversion guideline to a standard called Safe Prescribing of Opioids and 
Sedatives.  Some changes on the standard included strengthened language to ensure equal 
treatment of patients, greater clarity about dosage, tapering, and discontinuing opioids, and 
emphasis on documenting discussions with patients about the risk, storage, and disposal of the 
high-risk drugs (Unger).  The standard states providers must use appropriate and available 
strategies to mitigate risk of harm when prescribing or renewing opioids through reviewing 
medication profiles, considering random urine drug testing, and documenting recommendation of 
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take-home naloxone to patients at risk of respiratory depression taking opioids (CPSBC, 2018).  
Specifically, number three of the standard indicates providers must fully inform their patients of 
the risks and benefits including a “documented discussion of rationale for a treatment regimen, 
expectations and goals of patient and physician, alternative treatment strategies, and a plan for 
the eventual possible discontinuation of the medication” (p. 2).  This project’s focus was 
provider adherence to number three of the CPSBC standard. 
Problem, Aim, & Objectives 
Opioid treatment agreements are documented discussions explaining the risks and 
benefits of using LTOT for the diagnosed condition ensuring patients have enough information 
to provide consent agreeing to the prescribed opioid (McMaster University, 2017).  The OTA is 
an organized template prompting providers at the point of care to inform the patient about the 
opioid without missing important aspects.  The intended benefits of OTAs include clarification 
of expectations for patients and providers and provision of specific information around the nature 
of the opioid, goals, and management (McMaster, 2017).   
The aim of this project was to increase provider adherence to the CPSBC standard of 
informing patients about their LTOT use through completing OTAs with a two-part education 
and clinical reminder intervention over eight weeks of implementation.  The objectives of the 
project over eight weeks were:  
1. To determine providers’ pre- and post- knowledge of the opioid epidemic, CPSBC 
Safe Prescribing of Opioids and Sedatives standard, and OTAs after an education 
session on the topics.  
2. To increase overall post-intervention provider adherence to the CPSBC standard 
through completion of OTAs.  
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Literature Review 
 A literature review was conducted through databases Pubmed, Medline, and CINAHL for 
interventions used to increase provider adherence to clinical guidelines (See Appendix A for 
Database Search History).  Studies greater than eight years old, conducted outside of North 
America, and irrelevant to the Population, Intervention, Comparison, Outcome and Time 
(PICOT) were excluded.  The literature review included the latest evidence on provider 
adherence to clinical guidelines. 
Clinical guidelines are defined as “systematically developed statements to assist 
practitioners’ decisions about appropriate health care for specific clinical circumstances” 
(Fischer, Lange, Klose et al., 2016, p. 1).  They are valuable tools organizing the best evidence to 
support clinical decision making, improve quality of care, improve patient outcomes, and reduce 
cost.  In health care, guideline adherence constitutes desirable provider behavior correlated with 
positive patient outcomes.  Guideline adherence is best achieved when targeting provider and 
workflow level barriers through multifaceted interventions (Fischer et al.).   
Barriers to Guideline Adherence 
Fischer et al. (2016) stated barriers to guideline adherence strongly determine whether 
providers will follow clinical guidelines.  Provider level barriers are related to the provider’s 
knowledge and attitudes whereas workflow level barriers are related to guideline factors such as 
the process of developing a guideline and external factors linked to the availability of resources.  
Guideline adherence is best achieved when specific provider and workflow level barriers are 
identified and interventions are tailored to reduce or remove them (Fischer et al.).  For example, 
education is a tailored intervention understood to reduce or remove the provider level barrier, 
lack of knowledge, to improve guideline adherence by raising awareness and increasing 
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knowledge.  Alternatively, clinical reminders are a workflow level intervention minimizing 
contextual barriers thereby making it easier to adhere to guidelines.  Effective provider 
adherence is optimally achieved by combining both provider and workflow level interventions 
such as education and a clinical reminder which are described below (Fischer et al.).   
     Provider level interventions.  Common provider focused interventions included 
dissemination and education of the guideline (Fischer et al.).   
     Dissemination of guidelines.  Dissemination allows providers to have access and gain 
awareness of the guideline (Fischer et al., 2016).  Prior to dissemination, guideline developers 
may modify guidelines by changing the language and shortening the length for greater clarity.  
Standard guideline dissemination strategies included distributing through email, paper, and 
during education sessions (Fischer et al.).   
     Education.  Providing effective and engaging education on the guideline improves provider 
knowledge (Fischer et al., 2016).  Education in form of lectures and workshops showed small 
effects on improvement of a desired clinical practice change among providers (Gagne et al., 
2013).  An effective method of education was active learning which includes educational 
meetings, small group education, and one on one training (Gagne, Huse, McDavid et al., 2013).  
Such active learning strategies allow for feedback from the recipient(s) and mixing both 
interactive and didactic sessions showed as most effective in achieving provider engagement and 
adherence to guidelines.  Additionally, providing active learning education in combination with 
other interventions targeting provider guideline adherence were significantly more effective than 
any type of education alone (Gagne et al.).   
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     Workflow level interventions.  Workflow level interventions prompt health professionals to 
perform actions and adhere to guidelines.  One common workflow level intervention includes 
clinical reminders.  
     Clinical reminders.  Common clinical reminders allow for completion of health forms, 
screening tests, or diagnostic tests at the point of care by providers (Backman et al.).  The 
adoption of electronic medical record systems in health care during the past decade have made 
automated electronic clinical reminders a popular intervention for provider adherence to 
guidelines (Backman et al.).  However, Shojania et al. (2010) found automated electronic clinical 
reminders have small to modest improvements in alerting providers to complete clinical tasks at 
the point of care.  A more effective process to remind providers to complete tasks is facilitated 
by clinic staff such as medical office assistants (Wilkinson, Champion, & Sabharwal, 2013).  
Medical office assistants are valued staff members in primary care clinics with an important role 
to remind providers to complete forms or follow guidelines.  This process between the two 
professions is successful because medical office assistants help providers save time by reminding 
them to complete tasks that could have been missed (Wilkinson et al.).   
 In conclusion, the literature supported a multifaceted intervention targeting reduction of 
provider and workflow level barriers to improve provider adherence to guidelines.  The 
multifaceted intervention could include a combination intervention including education and a 
clinical reminder reducing both provider and workflow level barriers.  Education, when delivered 
via active learning, increases provider level awareness and knowledge of the guideline whereas 
the clinical reminder, when delivered by medical office assistants, decreases contextual barriers, 
both of which could successfully gain provider adherence to guidelines when combined.     
 
IMPROVING PROVIDER ADHERENCE  10 
 
 
Methods 
Design  
 This practice improvement project was conducted for eight weeks from January to March 
of 2019 evaluating the effectiveness of a two-part intervention consisting of education and a 
clinical reminder.  The design was a pre- and post- knowledge survey (secondary outcome) and 
chart review of OTA completion (primary outcome).  An OTA was included if it was signed by 
the patient and provider.   
Setting & Population 
 The setting for the project was a private primary care clinic with physician providers in 
the densely populated urban city center of Surrey, British Columbia.  The purpose of this clinic 
was to address health care needs for patients across the lifespan.  Some common patient 
presentations at the clinic included management of chronic diseases and addictions.  
Study Participants 
 The participants included eight primary care providers at the clinic.  The focus of the 
project was provider adherence to their standard to safely prescribe opioids for patients through 
completing OTAs.  Opioid treatment agreements completed on patients 18 years or older, on 
LTOT for a duration of three months or longer, who have a diagnosis of chronic pain, and who 
have no OTA on record when presenting for a clinical appointment were included in the project.  
Patients on LTOT for other reasons than chronic pain, such as cancer or addictions and those 
who had their opioid discontinued or diagnosed with acute pain were excluded.   
Implementation  
 The Quality Implementation Framework provided the foundation for the implementation 
of this project.  The Quality Implementation Framework offered an organized and systematic 
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guide through a series of steps and activities in four phases which enhance quality 
implementation to achieve the desired outcome of improved provider adherence (Meyers, 
Durlak, & Wandersman, 2012).  The framework indicates quality implementation is best 
achieved when delivered in phases consisting of multiple activities such as assessment, 
collaboration, negotiation, monitoring, and self-reflection (Meyers et al.).  By using this 
framework, it was proposed there will be improved understanding of strategies to gain provider 
adherence.  This project used the Quality Implementation Framework phases of planning, 
intervention part one and two, and evaluation to guide implementation.  
        Planning.  In the planning stage, the problem which was seldom completion of OTAs by 
providers was identified through a microsystem assessment of the clinic, an interview with the 
medical director, and a workflow analysis by shadowing provider and patient encounters.  The 
problem was then prioritized, and data was extracted from the electronic medical record for 
September to November of 2018 determining the pre-intervention rate of patients with 
documented OTAs, which was 4.9%.   
        Intervention.  The intervention stage included two parts: an education component and a 
clinical reminder component.  Providers and two medical office assistants received education on 
the opioid epidemic, revised standard, OTAs, and roles and responsibilities with a case exemplar 
and time for questions.  Staff received paper copies of the revised 2018 CPSBC standard and 
RxFiles OTA.  Following the education, the providers were given a written consent detailing the 
project and all eight signed agreeing to participate.  One barrier identified in the planning stage 
was the providers’ lack of knowledge on specific opioid related information.  Therefore, a three-
question knowledge survey on the components covered though the education was administered 
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in this stage to identify providers’ level understanding before and after following the session (See 
Appendix B for Knowledge Survey). 
 The second part of the intervention stage included the clinical reminder supporting 
implementation of the OTA.  The investigator conducted a prospective chart review twice per 
week on scheduled patients generating a list of patients who required an OTA.  This list of 
assigned patients was sent to one of the two designated medical office assistants who then 
delivered the clinical reminder to the providers prior to the patient’s appointment.  The medical 
office assistant printed the auto-filled OTA with the patient’s name from the electronic medical 
record, placed it in the designated provider’s mailbox, and sent an electronic message “reminder” 
for each assigned patient.  It was assumed once the medical office assistant sent the reminder, the 
provider would review the OTA with the patient.  During this part of the intervention, ongoing 
monitoring of the project occurred to ensure the medical office assistants were delivering the 
reminder.  
        Rx Files opioid treatment agreement.  The OTA chosen for implementation was adapted 
from the McMaster National Pain Centre and taken from RxFiles, a Canadian academic detailing 
program, that provides objective and comparative drug information to providers (RxFiles, 2014; 
See Appendix C for Opioid Treatment Agreement).  The OTA must be completed one time with 
patients taking LTOT.  The OTA is generally intended to be completed on initiation of LTOT 
but can be completed on following appointments as an outstanding task.  Through this project, 
providers were reminded to complete an OTA with LTOT patients if outstanding.  
        Evaluation.  The final stage was evaluation including data collection and analysis of the 
provider adherence rate to OTAs compared to the project’s objective.  The objective was to 
increase the adherence rate to the CPSBC standard through completing OTAs.  In this stage we 
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analyzed whether there was a large impact by the intervention on improving provider adherence.  
This stage also included reflection on the lessons learned and determination of sustainability of 
the practice change.   
   
 
1 Microsystems, 5P’s (Workflow), SWOT                  1 Implementation Team (DNP Student / Medical  
2 Problem Prioritization     Director/ 8 Providers / MOAs) 
3 Literature Search for Innovation          Intervention Stage Part One (education)  
4 Engagement & Fit      
Planning Stage 
 (baseline data)    
PHASE 1  PHASE 2 
    INITIAL    STRUCTURE FOR 
    CONSIDERATIONS IMPLEMENTATION 
 
PHASE 3  PHASE 4 
    ONGOING   LEARNING FROM 
    IMPLEMENTATION EXPERIENCE 
    SUPPORT   
 1 Implementation      
 2 Providing ongoing assistance (questions/troubleshoot)   
 3 Feedback from Providers    1 Lessons Learned (limitations/future implications) 
 4 Monitoring Implementation                                  2 Sustainability (use/modification) 
    Intervention Stage Part Two (reminder)                                              Evaluation Stage                           
 
Figure 1. The QIF underpinned the project in its four phases.  The three stages of 
implementation are highlighted in blue (planning, intervention, evaluation) and logically fit into 
the four phases of the QIF. 
 
  
Ethical Considerations 
 Institutional Review Board approval was obtained from the University of Portland in 
early December of 2018.  Written consent was obtained from all eight participants after the 
education session in early January of 2018.  Data collected from the electronic medical record 
including the patients on LTOT requiring OTAs were de-identified and analyzed in the aggregate 
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in terms of overall rates to maintain patient confidentiality.  The pre- and post- knowledge survey 
was anonymously completed by the provider participants.      
Data Collection  
A three-question knowledge survey was administered by paper to the providers right after 
the education to determine the change (See Appendix B for Knowledge Survey).  The survey 
score for each question pre- and post- knowledge ranged from 1 (none) to 4 (high).  The pre- and 
post-intervention data, which was the number of completed OTAs, was extracted through 
completing an electronic medical record chart review on the patients who received the reminder.  
The investigator reviewed the electronic medical record to determine whether an OTA was 
completed with eligible patients on LTOT by the providers.   
Data Analysis 
 Data were analyzed using Excel for both descriptive and inferential statistics.  Provider 
completion of OTAs prior to and following the intervention were recorded on Excel 
spreadsheets.  An alpha level of .05 was used to determine significance throughout.  A pre- and 
post- knowledge survey determining the change in providers’ knowledge of the education 
provided was analyzed for significance using a Wilcoxon signed-rank test.  This test was used 
given the small sample size and non-normal distribution of data.  The primary outcome was 
analyzed using a Chi-Square test evaluating if there was a statistically significant association 
between the two-part intervention (education session and clinical reminder) and provider 
adherence to OTA completion.     
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Results 
Knowledge Survey 
 Overall, among the seven providers who completed the three-question knowledge survey, 
findings demonstrated significant improvement (p = .017) in the providers’ average knowledge 
on the three parts (opioid epidemic, CPSBC standard, and OTAs) after (M = 3,7; SD = 0.33) 
compared to before (M .= 2.4; SD = 0.53) the education session.  Providers gained similar range 
of knowledge in all three parts of the education (see Table 1).  
 
Table 1     
Change in Provider Knowledge 
______________________________________________________________________________ 
Education Components Pre-Education  Post-Education SD  p  
 
The opioid epidemic    2.4   3.7  0.45  0.014 
in the Fraser Valley  
region. 
 
The updated CPSBC    2.4   3.6  0.50  0.011 
Safe Prescribing of  
Opiods and Sedatives  
standard (2018) 
 
Opioid treatment    2.4   3.9  0.35  0.026 
agreements. 
______________________________________________________________________________ 
 
Average               2.4   3.7  0.43  0.017 
______________________________________________________________________________ 
Note. SD = standard deviation; p = significance level 
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Provider Adherence Rate to Completing OTAs  
 A Chi-Square test was conducted to determine the association between the two-part 
intervention and provider completion of OTAs documented in the electronic medical record.  
The results demonstrated a significant association between receiving the education and clinical 
reminder intervention and completion of OTAs (X2(1) = 30.45, p < .05).   A greater proportion 
of patients had OTAs completed post-intervention compared to pre-intervention (See Table 2). 
 
Table 2  
Observed Frequencies  
 OTA   Pre-Intervention  Post-Intervention  Total 
No OTA   116 (95.1%)   35 (63.6%)  151 
Yes OTA   6 (4.9%)   20 (36.4%)  26 
Total    122    55   177 
______________________________________________________________________________ 
Note. The parenthesis indicates percent rate of provider adherence to completing OTAs.  
 
 
  A total of 6 out of 122 pre-intervention patients (4.9%) had an OTA completed in 
comparison to 20 out of 55 post -intervention patients (36.4%).  Therefore, provider adherence 
rate to number three of the CPSBC standard through completing OTAs post-intervention was 
36.4%.   
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Resources and Cost 
The investigator ensured a cost-effective practice change throughout the project.  
Therefore, there were minimal resources used or cost to this project.  A free OTA tool was used 
for the project.  A local electronic medical record expert, who did not charge a fee, directed us to 
an existing report query to gather relevant baseline data.  A lunch was provided by the project’s 
clinic corporation during the education session.  No participants were reimbursed financially for 
involvement in this practice change project.    
Discussion 
 The goal of this project was to improve provider guideline adherence to the CPSBC 
opioid prescribing standard for chronic noncancer pain patients on LTOT.  This project was 
conducted with a two-part intervention including an education session and clinical reminder over 
eight weeks with the objective to increase adherence to the standard through completion of 
OTAs.  At the end of the project, the 36.4% completion rate compared to the baseline 4.9% 
completion showed there was a significant improvement in provider adherence to their standard.   
 The literature supports using multifaceted interventions targeting provider and workflow 
level barriers as most successful to gain provider adherence.  The barriers at the clinic included 
lack of provider knowledge on the revised standard and forgetfulness to complete the OTA.  The 
results were congruent with the evidence as the two-part (multifaceted) intervention of education 
and the clinical reminder seemed to reduce these two barriers by improving provider knowledge 
and remembering to complete OTAs.   
 The Quality Implementation Framework was used to guide the implementation of this 
project.  The framework was successful in guiding the project in phases reducing barriers along 
the way.  Ongoing assistance to the providers and medical office assistants was an important part 
IMPROVING PROVIDER ADHERENCE  18 
 
 
for success when the project went live with the clinical reminder and OTA.  For example, 
providers at the clinic routinely covered each other’s patients providing opioid prescriptions and 
uncertain whether to complete the OTA with patients not listed under them.  It was established 
by the investigator all providers must complete their own OTA even when providing coverage.  
This was fundamental to clarify because if providers interpreted OTAs as only necessary to be 
completed by the most responsible provider, the results could have been inaccurate.  
 Ultimately, all phases in the Quality Implementation Framework were equally important 
to attain adherence by providers.  The framework guided reflection and measurement of project 
impact.  It was determined the two-part education and reminder intervention had a large impact 
on improving provider adherence to their standard through completing OTAs. 
 The project findings were beneficial because providers could mitigate opioid related risks 
by completing OTAs and decrease problematic prescriptions, which contribute to the opioid 
epidemic.  It is the provider’s ethical responsibility to inform patients on the opioid and one way 
is through completing the OTA.  The OTA also is a good way to open conversation with the 
patient to understand their risk of problematic use such as vulnerability to opioid misuse.  This 
way providers gain awareness of the patient’s problem and better strategize interventions to 
reduce risk.  
Limitations 
 There were four major limitations in this project.  The first limitation was the inability to 
distinguish between the two parts of the intervention in terms of effect on provider adherence.  
With the education intervention, although a knowledge survey was administered to compare pre- 
and post- knowledge scores after the session, the actual effect on provider adherence to complete 
OTAs was undetermined.  The data gathered and analyzed included pre-screened patients with 
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an upcoming appointment requiring an OTA whom the providers received reminders for.  In the 
duration of the project, it was undetermined whether providers completed OTAs on eligible 
patients without the reminder intervention such as for those newly initiated on LTOT or missed 
in screening.  It was beyond this project to isolate the two interventions as it was not more 
controlled with a comparison group.  Providers attitudes and feelings towards the two-part 
intervention in terms of effectiveness were also not evaluated post-intervention which may have 
been beneficial to reduce barriers and develop more effective interventions for the future.    
 The second limitation was a small sample size of providers and short duration of the 
project.  The post-intervention OTA patient group (N=55) was less than half the pre-intervention 
group (N=122) which was a less representative distribution of the population.  One reason for the 
smaller post-intervention result was due to screening limited to twice per week and encounters 
requiring OTAs being missed for the reminder intervention due to last minute appointments.  
The short eight-week duration of the project also threatened the validity and reliability of results.  
A longer duration project may have allowed for more post-intervention OTA encounters to 
increase validity and reliability.    
 The third limitation in this project was individual provider adherence rates were not the 
focus.  The adherence rate results were reported as the mean of all providers.  The rates could 
have varied significantly between providers swaying the results, probably due to multiple 
provider variables, which were not evaluated through this project.   
 The fourth and final limitation was the challenge to identify why providers failed to 
complete OTAs despite having the education and clinical reminder intervention.  Although 
identifying the reason for each case was beyond this project, the reasons may have included the 
following.  During the second part of the intervention stage of implementation, providers were 
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uncertain to complete OTAs with patients they were providing coverage for.  Providers may 
have intentionally ignored or refused completing OTAs in the period until it was clarified by the 
investigator that each provider must complete their own OTA.  Even after clarification providers 
may have continued to ignore or refuse to complete OTAs for other provider’s patients especially 
if solely refilling the opioid rather than initially prescribing or attending to a concern unrelated to 
pain. 
 Another reason was the documentation within the electronic medical record lacking 
clarity with some encounters but were included in the data.  As an attempt to gain the best data, 
each provider’s documentation of the unclear encounters was reviewed such as those listed as 
taking opioids for less than three-months and those not given a chronic noncancer pain diagnosis.  
The unclear encounters included in the data limited the validity and reliability of results.  To 
note, there was also only one investigator reviewing data creating room for interpretation 
mistakes which may have decreased the project’s accuracy. 
 Providers also did not consistently complete OTAs based on the reason for and time per 
appointment.  It was noted providers failed to complete OTAs with patients booked for 
appointments for 10 minutes or less and reasons unrelated to pain or an opioid prescription.   
This challenge was conveyed by a provider and the suggestion was to re-book the patient for a 
following appointment to complete the OTA.  Evaluation of whether providers re-booked 
patients was outside of the scope for this project.   
Implications for Practice 
 The results of this practice improvement project demonstrated increased provider 
awareness, knowledge, and confidence from the two-part intervention to gain adherence the 
CPSBC standard through OTAs.  Although the staff successfully integrated the OTA into 
IMPROVING PROVIDER ADHERENCE  21 
 
 
workflow for the project, it is uncertain whether medical office assistants will continue to remind 
the providers without a designated investigator reviewing charts and whether providers will 
continue completing OTAs without a reminder.  It is recommended a program champion, such as 
a medical office assistant, be appointed to screen for upcoming appointments of encounters 
requiring OTAs.  The reminder by the project champion may only be required for a short 
duration until the providers permanently change their behavior to complete OTAs as a routine 
workflow process.   
 It is also recommended for providers to stay up to date on opioid related 
guidelines/standards.  One way is through continuing education which helps sustain the change.  
It was evident by the pre- and post- knowledge survey education was necessary to learn about 
revisions on opioid prescribing guidelines which reinforced the importance of completing OTAs.   
Staff must also be satisfied with the practice change for sustainability.  Future projects should 
include post intervention survey(s) to gain knowledge on the attitudes and feelings of staff 
satisfaction with the new process.  Staff must be valued through implementation and an idea is 
having a project leader such as the medical director to motivate, provide support to, and gain 
feedback from staff consistently through any practice change initiative.   By having an effective 
leader, staff feedback is welcomed, and better strategies targeting provider and workflow level 
barriers are developed to gain provider adherence. 
Conclusion 
 The importance of quality interventions to improve the management of chronic 
noncancer pain patients on LTOT in primary care clinics is challenging but necessary for 
providers to mitigate the opioid epidemic in Canada.  This project consisted of a two-part 
intervention including education and a clinical reminder, delivered by medical office assistants to 
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the provider, to improve adherence to number three of the revised CPSBC standard for the safe 
prescribing of opioids.  The mandatory recommendation on number three of the standard is to 
complete comprehensive risk assessments with chronic noncancer pain patients and one way to 
meet this is by completing OTAs.  An OTA is an easy to follow document initiated by the 
provider serving as a contract with patients on LTOT outlining risks and benefits of opioids.  By 
participating in the two-part intervention, the providers showed increased knowledge on the 
epidemic, standard, and OTA and significant improvement in adherence to their standard through 
completing OTAs.  This project demonstrated the collaboration between providers and medical 
office assistants who took initiative to change a practice with the effort to mitigate the crisis of 
opioid related incidents to enhance patient safety.  
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Appendix B 
Knowledge Survey 
For each of the topics listed below, please check the box under the number that indicates your level of 
knowledge both before and after completing the course: 
1 = None – have no knowledge of the content 
2 = Low – know very little about the content 
3 = Moderate – have basic knowledge, there is more to learn 
4 = High – consider myself very knowledgeable 
How do you rate your 
knowledge about the 
following topics: 
 
Knowledge BEFORE this 
educational session 
Knowledge AFTER this educational 
session 
 1 2 3 4 1 2 3 4 
1. The opioid 
epidemic in the 
Fraser Valley 
region. 
 
        
2. The updated 
CPSBC Safe 
Prescribing of 
Opioids and 
Sedatives 
standard (2018). 
 
        
3. Opioid treatment 
agreements. 
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Appendix C 
Opioid Treatment Agreement 
See www.RxFiles.ca for customizable form (MS-Word format) for your office. 
Dirct link: http://www.rxfiles.ca/rxfiles/uploads/documents/Pain-CNMP-Opioid-TreatmentAGREEMENT.doc 
Adapted from www.PainCare.ca & 
http://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b05.html 
Sample Patient Agreement for Long-term Opioid Therapy 
1. I, _______________________________ agree that Dr. ____________________________ 
will be the only physician prescribing OPIOID (also known as NARCOTIC) pain medication 
for me and that I will obtain all of my prescriptions for opioids at one pharmacy. The 
exception would be an emergency situation or in the unlikely event that I run out of 
medication. Should such occasions occur, I will inform my physician as soon as possible. 
2. I will take the medication at the dose and frequency prescribed by my physician. I agree not 
to increase the dose of opioid without first discussing it with my physician. I will not request 
earlier prescription refills. 
3. I will attend all reasonable appointments, treatments and consultations as requested by my 
physician. I agree to other pain consultations/management strategies as necessary. 
4. I understand that the common side effects of opioid therapy include nausea, constipation, 
sweating and itchiness of the skin. Drowsiness may occur when starting opioid therapy or 
when increasing the dosage. I agree to refrain from driving a motor vehicle or operating 
dangerous machinery until such drowsiness disappears. 
5. I understand that using long-term opioids to treat chronic pain may result in the development 
of a physical dependence on this medication, and that sudden decreases or discontinuation of 
the medication will lead to the symptoms of opioid withdrawal. I understand that opioid 
withdrawal is uncomfortable but not life threatening. 
6. I understand that there is a small risk that I may become addicted to the opioids I am being 
prescribed. As such, my physician may require that I have blood, urine or hair testing and/or 
see a specialist in addiction medicine should a concern about addiction arise. 
7. I understand that the use of a mood-modifying substance, such as tranquilizers, sleeping pills, 
alcohol or illicit drugs (such as cannabis, cocaine, heroin or hallucinogens), can cause 
adverse effects or interfere with opioid therapy. Therefore I agree to refrain from the use of 
all of these substances without prior agreement from my physician. 
8. I understand that I should check with my physician or pharmacist before taking other 
medications including over-the-counter and herbal products. 
9. I agree to be responsible for the secure storage of my medication at all times. I agree not to 
give or sell my prescribed medication to any other person. Depending on the circumstances, 
lost medication may not be replaced until the next regular renewal date. 
10. I consent to open communication between my doctor and any other health care professionals 
involved in my pain management, such as pharmacists, other doctors, emergency 
departments, etc. 
11. I understand that if I break this agreement, my physician reserves the right to stop prescribing 
opioid medications for me. 
Date: ___________________________ 
________________________________ ______________________________ 
(Signature - Patient) (Signature Physician) 
